Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
UBS
AstraZeneca
McKesson
Fuji
Argus Health
Deloitte
Fish and Richardson

Generated: June 19, 2018

DrugPatentWatch Database Preview

PITAVASTATIN CALCIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for PITAVASTATIN CALCIUM
Synonyms for PITAVASTATIN CALCIUM
( )-(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid
(+)-monocalciumbis{(3r,5s,6e)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-hepten
(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
(3R,5S,6E)-7-(2-Cyclopropyl-4-(p-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid
(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic Acid Calcium Salt
(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid hemicalcium salt
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxy hept-6-enoic acid
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
(3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
(3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid
(3R,5S)-3,5-Dihydroxy-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-6-heptenoic acid
(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoate
(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-bis(oxidanyl)hept-6-enoate
(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
(E)-(3R,5S)-7-[2-Cyclopropyl-4-(4-fluoro-phenyl)-quinolin-3-yl]-3,5-dihydroxy-hept-6-enoic acid
(e)-(3r,5s)-7-[2-cyclopropyl-4-(4-fluoro-phenyl)-quinolin-3-yl]-3,5-dihydroxy-hept-6enoic acid
111GE002
1187847-92-2
121659-03-8
147511-69-1
147526-32-7
2299AH
2C25H23FNO4.Ca
3972AH
526P327
6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, (3R,5S,6E)-
6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, (S-(R*,S*-(E)))-
6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-, calcium salt (2:1), (S-(R*,S*-(E)))-
6-Heptenoic acid, 7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl)-3,5-dihydroxy-,calcium salt (2:1), (3R,5S,6E)-
6-HEPTENOIC ACID, 7-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-QUINOLINYL]-3,5-DIHYDROXY-, CALCIUM SALT (1:1), (3R,5S,6E)-
6-Heptenoic acid,7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, (3R,5S,6E)-
A808653
AB01274731-01
AB2000276
AC1NR03G
AC1NR03J
ACT02718
AJ-26824
AK-50694
AKOS005145916
AKOS015900407
AKOS025311204
Alipza
AM84440
AM84441
AN-6862
API0003879
AT-3425
BC654789
BDBM50371229
BDBM86707
Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate) monocalcium salt
Bis((3R,5S,6E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoate), monocalcium salt
BR-50694
C13334
C25H24FNO4
C50H46CaF2N2O8
Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
Calcium (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-hept-6-enoate
calcium (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate
calcium(2+) bis((3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate)
CAS_147511-69-1
CCG-101142
CCG-230641
CCRIS 8652
CHEBI:32020
CHEBI:71258
CHEBI:71260
CHEBI:94569
CHEMBL1201753
CHEMBL1237061
CJ-24282
CP0140
CPD000469287
CPD004727569
CS-2110
D01862
D0G1WL
D0H9WN
DB08860
DTXSID1048384
DTXSID4046448
E-(3R,5S)-7-[2-Cyclopropyl-4-(4fluoro-phenyl)quinolin-3-yl]-3,5-dihydroxy-hept-6-enoic acid
Flovas
GTPL3035
HE069357
HE312633
HMS2052O19
HMS3264F17
HSDB 8367
HY-B0144A
Itavastatin
ITAVASTATIN Ca
Itavastatin calcium
Itavastatin|||Nisvastatin|||NK-104|||P-872441|||(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
Itavastin
IYD54XEG3W
KS-1220
Livalo
Livalo (TN)
Livazo
LS-190698
LS-74594
LS-74595
M5681Q5F9P
MFCD01937979
MLS001401466
MLS006010096
MolPort-003-987-536
MolPort-006-822-984
NC00392
Nisvastatin
NK 104
NK 104 (acid)
NK-104
NKS-104
NSC-760423
NSC760423
P 872441
P-872441
Pharmakon1600-01502374
Pitava
Pitava 1
pitavastatia
Pitavastatin
Pitavastatin [INN]
Pitavastatin calcium (JAN)
Pitavastatin calcium /NK-104
pitavastatin calcium hydrate
Pitavastatin calcium salt
Pitavastatin CalciumDISCONTINUED
pitavastatin cation
Pitavastatin hemicalcium
pitavastatin(1-)
pitavastatine
pitavastatinum
Q-201590
Redevant
RHGYHLPFVJEAOC-FFNUKLMVSA-L
SAM001246803
SC-18906
SCHEMBL15476618
SCHEMBL22720
SCHEMBL3369
SCHEMBL464781
SMR000469287
SMR003965244
ST24030237
TL8006181
UNII-IYD54XEG3W
UNII-M5681Q5F9P
VGYFMXBACGZSIL-MCBHFWOFSA-N
ZINC1534965
Zypitamag

US Patents and Regulatory Information for PITAVASTATIN CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd PITAVASTATIN CALCIUM pitavastatin calcium TABLET;ORAL 206015-001 Dec 20, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sawai Usa PITAVASTATIN CALCIUM pitavastatin calcium TABLET;ORAL 205955-001 Feb 3, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orient Pharma Co Ltd PITAVASTATIN CALCIUM pitavastatin calcium TABLET;ORAL 205932-001 Feb 3, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sawai Usa PITAVASTATIN CALCIUM pitavastatin calcium TABLET;ORAL 205955-002 Feb 3, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Dow
Mallinckrodt
Medtronic
US Department of Justice
Argus Health
AstraZeneca
QuintilesIMS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.